Announcements

Home/News/Announcements

Improved Pharma announces new collaboration with Chyall Pharma

WEST LAFAYETTE, IND. (PRWEB) NOVEMBER 21, 2022 Improved Pharma is pleased to announce a new collaboration with Chyall Pharmaceutical Consulting, LLC (dba “Chyall Pharma”) enabling expansion of expertise and service offerings to the pharmaceutical industry in support of drug substance and drug product development. Chyall Pharma’s founder and President Dr. Leonard (“Len”) Chyall will serve as Read more

Improved Pharma announces new collaboration with Chyall Pharma2022-11-21T19:45:49+00:00

Unsafe Pharmaceuticals: Fake or Counterfeit

On Monday, November 14, Dr. Dale K. Purcell, President of Chemical Microscopy and consultant with Improved Pharma, will present an invited speaker “Unsafe Pharmaceuticals: Fake or Counterfeit” in the POWERHOUSE SESSION: Challenges of Counterfeit Detection in Pharmaceutical Industry.  The need to combat counterfeiting pharmaceutical drugs, the pharmaceutical packaging sector has largely implemented advanced package labeling Read more

Unsafe Pharmaceuticals: Fake or Counterfeit2022-11-07T21:20:16+00:00

Improved Pharma presenting at AAPS 2022 PHARMSCI 360 with Rapid Fire Presentation and Posters

WEST LAFAYETTE, IND. (PRWEB) SEPTEMBER 27, 2022 Improved Pharma is presenting their research on all three days of the AAPS conference. On Monday October 17th at 2:30 pm, please visit monitor #31 in forum 6. Ms. Ruba Alajlouni will present “Feasibility of Synchrotron XRD for the analysis of mixture sub-samples.” She will share results demonstrating the effective Read more

Improved Pharma presenting at AAPS 2022 PHARMSCI 360 with Rapid Fire Presentation and Posters2022-10-11T11:33:45+00:00

Improved Pharma Obtains DEA Registration for Schedules I – V

DEA registration allows Improved Pharma to support pharmaceutical development for all types of controlled substances. WEST LAFAYETTE, IND. (PRWEB) SEPTEMBER 19, 2022 Improved Pharma is pleased to announce their DEA registration for schedules I – V. The new controlled substance license enhances the wide variety of drug substances and drug products that can now be Read more

Improved Pharma Obtains DEA Registration for Schedules I – V2022-09-19T13:18:00+00:00

Improved Pharma announces new collaboration with Keystone Pharma Consulting

WEST LAFAYETTE, Ind. (PRWEB)May 11, 2022 Improved Pharma is pleased to announce a collaboration with Dr. Patricia Andres from Keystone Pharma Consulting, LLC, thus further expanding its network of pharmaceutical consultants with expertise in different areas of drug development to support its growing demand. Dr. Andres, President and founder of Keystone Pharma Consulting, LLC, Read more

Improved Pharma announces new collaboration with Keystone Pharma Consulting2022-07-27T13:36:24+00:00

Improved Pharma Expands Service Offerings with Addition of VTI Corp. SGA-100 DVS for Measurement of Hygroscopicity

Improved Pharma is pleased to announce expanded capabilities with the addition of an in-house SGA-100 DVS. DVS is very useful in understanding if material is hygroscopic, and subsequently if it will lose the adsorbed water, or if material is deliquescent. In addition, DVS can aid in the identification of potential hydrates, which may be Read more

Improved Pharma Expands Service Offerings with Addition of VTI Corp. SGA-100 DVS for Measurement of Hygroscopicity2022-04-25T15:47:03+00:00

Patenting and Litigating Pharmaceutical Salts

On Thursday, April 28, at 12:30 PM ET, please join Gene Quinn, President & CEO of IPWatchdog, Inc., and our distinguished panel consisting of Dr. Stephen Byrn of Purdue University and Improved Pharma, Dr. Steven Zeman, partner and European and German patent attorney at the firm Grünecker Patent Attorneys and Attorneys at Law in Munich, Germany, and Eyal Barash, a U.S. Read more

Patenting and Litigating Pharmaceutical Salts2022-04-25T15:42:14+00:00

Improved Pharma returns to Sustainable Medicines in Africa Program

The Sustainable Medicines in Africa program, which includes a master’s degree in biotechnology innovation and regulatory science from Purdue University, returned to Arusha, Tanzania in March of 2022.  About 100 students and instructors gathered in the vast complex at St. Carolus for two weeks, participating in group projects, laboratory experiments, and lectures. The topics Read more

Improved Pharma returns to Sustainable Medicines in Africa Program2022-04-18T11:58:08+00:00

American Crystallographic Association (ACA) Summer Course in Chemical Crystallography

WEST LAFAYETTE, Ind. (PRWEB)January 19, 2022 Improved Pharma is pleased to announce its sponsorship towards the 2022 ACA Summer Course in Crystallography to be held this summer at Purdue University. The course aim is to provide appropriate training on the theory as well as practical aspects of both Single Crystal Chemical Crystallography and X-Ray Read more

American Crystallographic Association (ACA) Summer Course in Chemical Crystallography2022-01-24T18:22:52+00:00

Improved Pharma Announces Pharmaceutical R&D Efforts in 2021

WEST LAFAYETTE, Ind. (PRWEB)January 14, 2022 Developing new tools and advancing pharmaceutical development is a key part of Improved Pharma’s mission. In 2021, the results from several research and development projects were published with our team of consultants and collaborators. Most of the research focused on the development of amorphous materials and understanding their Read more

Improved Pharma Announces Pharmaceutical R&D Efforts in 20212022-01-14T20:08:42+00:00
Go to Top